tumor
metastasi
main
featur
malign
tumor
often
consid
lethal
properti
cancer
cell
process
tumor
metastasi
complex
continu
multifactori
tissuespecif
interact
play
critic
role
initi
tumor
metastasi
process
regul
specif
tissu
cell
well
cancer
cell
perspect
organ
microenviron
vessel
diamet
capillari
wall
structur
composit
blood
vessel
affect
tumour
cell
infiltr
capillari
liver
lymph
node
found
line
fenestr
endotheli
cell
thu
permiss
recruit
tumour
cell
furthermor
specif
ligand
endotheli
cell
also
involv
tumor
metastasi
time
tumor
cell
optim
motil
depend
environ
surround
tissu
regul
express
specif
receptor
cell
surfac
synergist
facilit
organspecif
metastasi
dcsignr
dendrit
cellspecif
intercellular
adhes
moleculegrab
nonintegrinrel
protein
ctype
ii
integr
membran
protein
predominantli
found
sinusoid
endotheli
cell
liver
lymph
node
well
placent
endothelium
gener
import
dcsignr
due
role
celladhes
receptor
high
affin
lewisa
lewisb
lewisi
dcsignr
also
involv
innat
immun
system
recogn
divers
pathogen
rang
virus
parasit
tremend
impact
public
health
report
play
import
role
variou
pathophysiolog
condit
hepat
c
hiv
sever
acut
respiratori
syndrom
lsectin
belong
subfamili
includ
dcsignr
dcsign
also
found
liver
sinusoid
endotheli
cell
demonstr
lsectin
crucial
regul
colon
cancer
liver
metastasi
serum
lsectin
level
patient
colon
cancer
liver
metastasi
higher
patient
without
metastasi
lsectin
increas
express
cmet
colon
cancer
cell
recent
laboratori
report
level
serum
dcsignr
colon
cancer
patient
higher
healthi
volunt
dcsignr
may
signific
biomark
could
use
diagnosi
earli
stage
colon
cancer
furthermor
mani
ctype
lectin
also
demonstr
involv
tumour
metastasi
christoph
r
parish
et
al
found
endothelialderiv
pselectin
import
plateletderiv
pselectin
aggrav
lung
metastas
particip
liver
metastasi
sayeda
yasminkarim
emphas
interact
eselectin
eselectin
ligand
mediat
roll
adhes
prostat
cancer
cell
endotheli
surfac
raserkmap
kinas
pathway
mannos
receptor
promot
colon
carcinoma
cell
interact
liver
sinusoid
endothelium
contribut
colon
cancer
hepat
metastasi
induc
therefor
hypothes
dcsignr
could
also
associ
human
colon
cancer
progress
metallothionein
group
evolutionarili
conserv
low
molecular
weight
cysteinerich
protein
metallothionein
gene
locat
chromosom
human
four
primari
metallothionein
isoform
wherea
commonli
express
seem
restrict
brain
specif
found
certain
squamou
epitheli
tissu
furthermor
eight
function
paralog
metallothionein
redoxact
protein
mani
function
includ
zinc
homeostasi
heavi
metal
detoxif
metal
transfer
facilit
chemoresist
anticanc
drug
recent
year
metallothionein
shown
relat
tumor
stage
therapi
resist
poor
prognosi
surviv
mani
cancer
studi
aim
gain
insight
import
biolog
effect
dcsignr
colon
cancer
found
colon
cancer
patient
liver
metastasi
show
higher
level
dcsignr
compar
patient
without
metastasi
addit
dcsignr
express
could
induc
colon
cancer
cell
variou
chang
tumour
microenviron
furthermor
dcsignr
mediat
upregul
metallothionein
vitro
vivo
experi
perform
elucid
relev
dcsignrmedi
tumor
metastasi
inhibit
dcsignr
activ
downstream
dcsignrregul
event
could
therapeut
intervent
colon
cancer
format
colon
cancer
cell
lovo
use
research
cell
cultur
rpmi
medium
supplement
fetal
bovin
serum
uml
penicillin
streptomycin
beyotim
china
cell
maintain
incub
humidifi
air
sixtoeightweek
old
nude
mice
purchas
dalian
medic
univers
dalian
china
bred
acclim
specif
pathogenfre
condit
anim
studi
conduct
accord
institut
anim
care
use
committe
dalian
medic
univers
total
patient
colon
cancer
enrol
studi
patient
treat
first
second
affili
hospit
dalian
medic
univers
none
patient
immedi
rel
clinic
inform
patient
list
addit
file
tabl
control
group
consist
healthi
volunt
clinic
materi
research
approv
research
ethic
committe
dalian
medic
univers
dcsignr
express
plasmid
produc
depend
cdna
fragment
contain
full
code
sequenc
dcsignr
nt
two
shrna
sequenc
knockdown
mous
dcsignr
shrna
shrna
b
neg
control
vector
contain
nonsens
sequenc
signific
homolog
target
sequenc
plasmid
design
synthes
shanghai
gene
pharma
shanghai
china
serum
level
dcsignr
measur
use
commerci
sandwich
enzymelink
immunosorb
assay
method
well
micropl
coat
antidcsignr
goat
polyclon
antibodi
santa
cruz
biotechnolog
inc
usa
final
concentr
captur
antibodi
incub
overnight
plate
wash
three
time
phosphat
buffer
salin
pb
contain
pbst
ph
well
block
block
buffer
bovin
serum
albumin
h
plate
wash
three
time
pbst
dilut
rhdcsignrfc
standard
ad
well
along
serum
colon
cancer
patient
healthi
control
neg
control
pb
use
plate
incub
h
subsequ
pbst
use
wash
plate
three
time
antidcsignr
mous
monoclon
antibodi
r
system
inc
usa
dilut
concentr
ad
well
plate
incub
h
wash
peroxidaseconjug
goat
antimous
antibodi
zsgbbio
china
ad
plate
incub
h
final
plate
wash
three
time
incub
tmb
tiangen
biotech
co
ltd
h
moll
ad
stop
reaction
optic
densiti
od
measur
wavelength
nm
micropl
reader
quantit
dcsignr
concentr
determin
compar
optic
densiti
valu
standard
curv
addit
file
figur
colon
cancer
cell
line
lovo
treat
recombin
human
dcsignr
protein
control
igg
ice
h
detect
interact
cell
protein
cell
incub
antidcsignr
mous
monoclon
antibodi
r
system
inc
usa
ice
h
cell
gentli
wash
three
time
pb
fluorescein
isothiocyanateconjug
goat
antimous
igg
secondari
antibodi
zsgbbio
china
ad
cell
incub
ice
anoth
h
cell
wash
fix
paraformaldehyd
adher
cell
measur
next
day
use
facscalibur
instrument
bd
bioscienc
usa
inhibit
assay
dcsignr
protein
preincub
select
ligand
includ
edta
dmannos
galactos
nacetylglucosamin
lfucos
cell
treat
recombin
dcsignr
protein
control
igg
vitro
migrat
assay
perform
plate
transwel
insert
mm
diamet
pore
size
corn
usa
invas
assay
cell
incub
matrigelco
membran
insert
cell
incub
h
cell
upper
membran
migrat
invad
remov
use
cotton
swab
subsequ
cell
lower
side
membran
fix
methanol
min
stain
crystal
violet
min
wound
heal
assay
cell
monolay
wound
steril
pipet
tip
cell
nearli
confluent
movement
cell
photograph
monitor
h
wound
imag
taken
indic
time
point
olympu
japan
lovo
colon
cancer
cell
seed
sixwel
plate
densiti
cell
per
well
cell
treat
dcsignr
protein
control
igg
incub
day
humidifi
atmospher
visibl
clone
appear
cell
wash
pb
stain
crystal
violet
methanol
min
coloni
cell
count
use
optic
microscop
olympu
japan
nake
plasmid
dna
administ
mice
larg
volum
via
tail
vein
inject
volum
solut
use
correspond
bodi
weight
mous
ie
ml
inject
complet
within
total
rna
isol
liver
tissu
use
trizol
reagent
takara
bio
japan
human
dcsignr
transcript
amplifi
follow
primer
forward
primer
revers
primer
mous
dcsignr
primer
forward
primer
revers
primer
select
endogen
control
amplifi
use
follow
primer
forward
primer
revers
primer
pcr
amplif
product
distinguish
agaros
pronadisa
spain
gel
contain
gold
view
visual
uv
transillumin
protein
mous
liver
tissu
lovo
cell
extract
separ
trisglycin
gel
western
blot
analys
perform
accord
standard
procedur
protein
extract
immunoblot
mous
dcsignr
antibodi
r
system
inc
usa
human
dcsignr
antibodi
abcam
usa
metallothionein
antibodi
biosynthesi
biotechnolog
china
antibodi
elabsci
biotechnolog
china
antibodi
use
control
mice
anaesthet
pentobarbit
sodium
sigma
usa
mgkg
bodi
weight
intrasplen
inject
incis
made
left
flank
spleen
separ
exterior
lovo
cell
inject
spleen
spleen
return
abdomin
caviti
wound
sutur
sign
abdomin
distens
locomot
deficit
appear
tumor
detect
palpat
mice
kill
liver
spleen
harvest
tissu
slide
deparaffin
rehydr
boil
citrat
buffer
tissu
section
incub
primari
bioworld
technolog
china
cea
bioworld
technolog
china
bioworld
technolog
china
proteintech
china
antibodi
overnight
section
incub
hrpconjug
antirabbit
antibodi
zsgbbio
china
min
stain
dab
counterstain
haematoxylin
lovo
cell
incub
recombin
dcsignr
protein
control
igg
h
total
rna
isol
analyz
affymetrix
genechip
primeviewtm
human
gene
express
array
affymetrix
santa
clara
ca
chip
probe
set
repres
gene
complet
annot
refseq
rna
databas
quantit
realtim
pcr
use
valid
chang
express
metallothionein
colon
cancer
cell
cdna
synthes
use
primescript
ii
strand
cdna
synthesi
kit
takara
bio
japan
pcr
reaction
perform
least
triplic
result
analys
thermal
cycler
dice
realtim
system
takara
bio
japan
use
sybr
premix
ex
taqtm
pcr
master
mix
takara
bio
japan
gapdh
select
endogen
control
primer
pair
use
pcr
present
addit
file
tabl
fold
chang
gene
calcul
use
deltadelta
ct
method
data
present
mean
sd
indic
comparison
two
group
assess
use
unpair
twotail
test
oneway
anova
tukey
multipl
test
use
comparison
multipl
group
nonparametr
mannwhiney
u
test
employ
analys
associ
dcsignr
level
variou
clinicopatholog
characterist
surviv
analysi
perform
use
logrank
mantelcox
test
test
p
valu
consid
signific
result
reproduc
across
triplic
experi
statist
analys
carri
use
graphpad
prism
graphpad
softwar
inc
usa
dcsignr
act
adhes
receptor
first
wonder
whether
dcsignr
associ
metastat
potenti
colon
cancer
cell
examin
capabl
dcsignr
protein
bind
colon
cancer
cell
dcsignr
recombin
protein
r
system
inc
usa
encod
extracellular
domain
ser
human
dcsignr
stabli
express
mous
myeloma
cell
line
deriv
cell
nonig
secret
nonlight
chainsynthes
cell
line
gene
engin
techniqu
seri
extract
purif
process
fcdcsignr
chimera
gener
use
mani
applic
verifi
express
human
fcdcsignr
western
blot
analysi
fig
use
cell
infect
lentiviru
express
dcsignr
posit
control
express
dcsignr
detect
use
dcsignr
primari
antibodi
abcam
usa
peroxidaseconjug
antirabbit
igg
secondari
antibodi
zsgbbio
china
predict
molecular
weight
antibodi
kda
addit
predict
molecular
weight
recombin
human
dcsignr
chimera
protein
kda
base
migrat
sdspage
gel
treat
three
colon
cancer
cell
line
lovo
human
dcsignr
mous
igg
isotyp
control
ice
h
mous
igg
isotyp
control
use
block
nonspecif
bind
site
antidcsignr
mous
primari
antibodi
result
indic
dcsignr
protein
bound
strongli
three
cell
type
respect
adhes
ratio
lovo
cell
cell
cell
fig
notabl
bind
dcsignr
protein
lovo
cell
occur
dosedepend
manner
fig
dcsignr
ctype
ii
transmembran
lectin
contain
calciumdepend
carbohydr
recognit
domain
crd
second
site
analog
identifi
mannosebind
protein
addit
dcsignr
select
bind
monosaccharid
manner
suggest
bind
site
analog
observ
ctype
lectin
crd
therefor
sought
determin
whether
dcsignr
could
recogn
ligand
colon
cancer
cell
calcium
mannosedepend
bind
result
show
bind
dcsignr
colon
cancer
cell
requir
presenc
bind
inhibit
addit
bind
chelat
edta
fig
interact
could
also
block
addit
monosaccharid
name
dmannos
galactos
nacetylglucosamin
lfucos
fig
thu
data
indic
interact
dcsignr
colon
cancer
cell
may
calciumdepend
dcsignr
may
bind
colon
cancer
cell
proteinglycan
interact
two
main
characterist
metastat
cancer
cell
migrat
abil
degrad
physic
barrier
extracellular
matrix
compon
invad
new
tissu
assess
effect
dcsignr
cell
motil
invas
use
transwel
insert
describ
found
dcsignr
protein
markedli
enhanc
migrat
three
type
colon
cancer
cell
cell
invad
matrigeltm
dcsignr
proteintr
group
untreat
group
fig
b
valid
result
also
observ
cell
morpholog
perform
wound
heal
assay
compar
morpholog
cell
describ
light
microscop
observ
dcsignr
could
induc
scatter
colon
cancer
cell
chang
morpholog
cell
epitheliallik
elong
cell
shape
fig
typifi
morpholog
polar
consist
format
protrus
process
cell
migrat
addit
woundheal
assay
cancer
cell
treat
dcsignr
protein
abl
heal
inflict
wound
significantli
faster
untreat
control
cell
fig
e
taken
togeth
data
impli
dcsignr
may
confer
migrat
invas
abil
colon
cancer
cell
confirm
whether
result
vitro
migrat
invas
assay
due
differ
cellular
prolifer
three
type
colon
cancer
cell
measur
cell
growth
rate
use
coloni
format
assay
signific
differ
number
coloni
observ
cell
treat
dcsignr
protein
treat
control
igg
addit
file
figur
b
taken
togeth
data
impli
dcsignr
confer
migrat
invas
abil
colon
cancer
cell
without
alter
prolifer
cell
result
indic
dcsignr
enhanc
colon
cancer
cell
adhes
migrat
invas
liver
main
site
dcsignr
product
metastasi
liver
characterist
step
develop
colon
cancer
thu
want
explor
role
mous
dcsignr
process
demonstr
plasmid
dna
effici
deliv
liver
hydrodynam
tail
vein
procedur
allow
elucid
role
gene
diseas
develop
anim
model
first
inject
two
differ
mous
dcsignr
shrna
plasmid
control
shrna
plasmid
tail
vein
nude
mice
effect
two
mous
dcsignr
shrna
determin
rtpcr
western
blot
analysi
day
fig
b
compar
control
shrna
dcsignr
shrna
could
reduc
express
mous
dcsignr
addit
mous
dcsignr
shrna
effici
mous
dcsignr
shrna
b
thu
chose
use
mous
dcsignr
shrna
subsequ
studi
also
studi
express
mous
dcsignr
differ
organ
inject
mous
dcsignr
shrna
plasmid
addit
file
figur
b
result
show
mous
dcsignr
shrna
plasmid
significantli
decreas
express
mous
dcsignr
liver
wherea
gene
express
organ
spleen
lung
chang
inject
mous
dcsignr
shrna
plasmid
determin
decreas
express
mous
dcsignr
could
detect
day
mous
dcsignr
shrna
plasmid
tail
vein
inject
level
mous
dcsignr
gene
express
depend
amount
mous
dcsignr
shrna
plasmid
inject
thu
use
differ
dose
mous
dcsignr
shrna
plasmid
tail
vein
inject
experi
fig
accord
result
inject
mous
dcsignr
shrna
plasmid
per
mous
effici
dose
consequ
chose
optim
dose
mous
dcsignr
shrna
plasmid
studi
suppress
mous
dcsignr
mous
liver
evalu
express
mous
dcsignr
time
inject
mous
dcsignr
shrna
fig
shrna
effect
third
day
tail
vein
inject
fifth
seventh
day
distinct
decreas
mous
dcsignr
express
howev
tenth
day
statist
effect
express
mous
dcsignr
result
suggest
mous
dcsignr
shrna
significantli
decreas
express
mous
dcsignr
effect
may
last
day
vivo
next
examin
whether
mdcsignr
could
bind
colon
cancer
cell
lovo
colon
cancer
cell
incub
frozen
liver
section
obtain
mice
day
treatment
either
mous
dcsignr
shrna
plasmid
control
shrna
plasmid
tail
vein
inject
fig
f
result
show
compar
control
shrna
group
adhes
colon
cancer
cell
mous
liver
tissu
treat
mous
dcsignr
shrna
significantli
decreas
data
demonstr
knockdown
mous
dcsignr
affect
adhes
human
colon
cancer
cell
liver
tissu
treat
mice
mous
dcsignr
shrna
plasmid
control
shrna
plasmid
via
tail
vein
inject
day
lovo
cell
inject
spleen
nude
mice
mous
dcsignr
shrna
control
shrna
readminist
tail
vein
inject
everi
day
result
show
mous
dcsignr
shrna
significantli
attenu
metastasi
lovo
cell
liver
comparison
control
shrna
fig
addit
mous
dcsignr
shrna
influenc
local
growth
colon
cancer
cell
kaplanmei
surviv
curv
gener
compar
condit
mice
inject
two
differ
cell
line
treat
either
mous
dcsignr
control
shrna
found
mice
inject
lovo
cell
surviv
percentag
mice
mous
dcsignr
shrna
group
significantli
higher
control
shrna
group
fig
result
obtain
mice
inject
cell
moreov
observ
histolog
chang
liver
surround
metastat
foci
h
e
stain
reveal
knock
mous
dcsignr
significantli
decreas
potenc
lovo
cell
liver
metastasi
howev
differ
spleen
tumor
mous
dcsignr
shrna
group
control
group
fig
furthermor
measur
mean
tumour
volum
group
calcul
number
metastat
foci
liver
spleen
fig
k
tumor
volum
mous
dcsignr
shrna
group
smaller
mice
develop
fewer
micrometastat
foci
liver
tissu
mous
dcsignr
shrna
experiment
group
compar
control
group
howev
mous
dcsignr
shrna
plasmid
exert
effect
local
growth
colon
cancer
cell
data
impli
mous
dcsignr
knockdown
inhibit
colon
cancer
liver
metastasi
vivo
find
demonstr
mous
dcsignr
involv
colon
cancer
liver
metastasi
howev
role
human
dcsignr
process
studi
thu
also
use
hydrodynam
inject
induc
effect
express
exogen
human
dcsignr
mous
liver
effect
human
dcsignr
express
plasmid
examin
rtpcr
western
blot
analysi
day
fig
b
found
human
dcsignr
express
mous
liver
tail
vein
inject
human
dcsignr
plasmid
inject
differ
dose
human
dcsignr
plasmid
consequ
identifi
optim
dose
human
dcsignr
express
fig
inject
mice
human
dcsignr
plasmid
observ
gene
express
liver
time
found
human
dcsignr
plasmid
obviou
effect
first
second
day
inject
howev
gene
express
gradual
attenu
seventh
day
observ
faint
dcsignr
express
liver
tissu
fig
find
indic
human
dcsignr
express
mous
liver
human
dcsignr
plasmid
tail
vein
inject
effect
may
last
day
addit
detect
whether
human
dcsignr
could
adher
liver
tissu
mice
incub
lovo
colon
cancer
cell
frozen
liver
tissu
mice
treat
human
dcsignr
plasmid
empti
plasmid
day
found
significantli
cell
adher
liver
tissu
dcsignr
plasmid
group
compar
control
group
adhes
action
inhibit
antidcsignr
antibodi
abcam
usa
fig
f
studi
show
express
human
dcsignr
mous
liver
induc
hydromechan
plasmid
applic
could
feasibl
attract
colon
cancer
cell
adher
liver
tissu
thu
demonstr
human
dcsigr
could
bind
liver
tissu
mice
necessari
explor
whether
human
dcsignr
also
relat
colon
cancer
liver
metastasi
nude
mice
first
administ
human
dcsignr
plasmid
empti
plasmid
tail
vein
inject
day
lovo
cell
inject
spleen
mice
inject
human
dcsignr
plasmid
empti
plasmid
repeat
everi
day
compar
control
group
liver
metastas
volum
much
larger
mice
inject
three
colon
cancer
cell
line
treat
human
dcsignr
plasmid
fig
addit
differ
volum
spleen
tumour
human
dcsignr
plasmid
group
control
group
next
observ
histolog
chang
liver
surround
metastat
foci
local
spleen
tumour
h
e
stain
immunohistochem
stain
cea
fig
addit
file
figur
h
e
stain
metastas
confirm
homolog
colon
cancer
cell
colon
cancer
cell
human
dcsignr
plasmid
group
comparison
empti
plasmid
group
stain
indic
hyperprolif
tumour
cell
found
liver
tissu
human
dcsignr
plasmid
group
compar
control
group
furthermor
also
measur
tumor
volum
count
number
metastat
foci
liver
spleen
group
inject
differ
colon
cancer
cell
line
fig
j
compar
empti
plasmid
group
liver
tumor
grew
much
larger
human
dcsignr
plasmid
group
addit
human
dcsignr
plasmid
surprisingli
induc
micrometastat
liver
foci
compar
empti
plasmid
addit
mice
inject
three
cell
line
differ
tumor
volum
number
tumor
per
spleen
group
treat
human
dcsignr
plasmid
group
treat
empti
plasmid
sum
data
confirm
dcsignr
may
particip
colon
cancer
cell
metastat
progress
liver
reveal
molecular
alter
induc
dcsignr
colon
cancer
cell
util
profil
data
affymetrix
genechip
primeview
human
gene
express
array
lovo
cell
incub
dcsignr
protein
control
igg
h
total
gene
pass
filter
criteria
analys
among
gene
express
profil
metallothionein
famili
member
could
readili
distinguish
dcsignr
proteintr
cell
control
cell
fig
interestingli
differ
gene
relat
tumour
metastasi
met
tabl
notabl
averag
median
express
valu
metallothionein
higher
fcdcsignr
test
group
fccontrol
group
fig
addit
file
tabl
valid
array
result
semiquantit
rtpcr
western
blot
analysi
perform
fig
addit
file
figur
b
detect
express
metallothionein
lovo
cell
incub
differ
length
time
dcsignr
protein
control
igg
consist
microarray
data
cell
line
treat
dcsignr
protein
show
intens
signal
control
cell
h
incub
addit
express
metallothionein
gradual
decreas
timedepend
manner
fcdcsignr
group
sever
studi
report
metallothionein
capabl
mediat
express
result
demonstr
dcsignr
protein
could
significantli
increas
express
metallothionein
h
incub
thu
want
know
whether
dcsignr
could
alter
express
interestingli
found
dcsignr
also
increas
express
lovo
cell
h
incub
gene
analys
gene
express
array
fig
f
furthermor
explor
relationship
metallothionein
colon
cancer
cell
result
found
obviou
chang
protein
express
upregul
obvious
metallothionein
knockdown
lovo
cell
fig
silenc
significantli
decreas
express
metallothionein
lovo
cell
determin
western
blot
analysi
fig
addit
also
review
syndic
bioinformat
use
molecul
annot
system
found
metallothionein
mani
bind
site
involv
mani
biolog
process
express
mainli
cytoplasm
fig
evid
reveal
dcsignr
regul
express
metallothionein
upregul
colon
cancer
liver
metastasi
cell
adhes
molecul
import
mediat
process
tumor
growth
metastasi
releas
circul
intern
rapidli
shear
condit
addit
increas
serum
level
adhes
molecul
report
correl
tumour
metastasi
studi
examin
serum
level
dcsignr
colon
cancer
patient
detect
relationship
solubl
dcsignr
colon
cancer
liver
metastasi
investig
particip
total
serum
level
dcsignr
colon
cancer
patient
n
healthi
control
n
analys
standard
sandwich
elisa
tabl
result
show
serum
dcsignr
level
significantli
differ
colon
cancer
patient
stage
iiiiv
ngml
healthi
individu
ngml
p
fig
addit
detect
serum
concentr
dcsignr
significantli
higher
colon
cancer
patient
liver
metastasi
ngml
patient
without
metastasi
ngml
p
fig
result
valid
solubl
dcsignr
may
correl
process
colon
cancer
liver
metastasi
studi
demonstr
dcsignr
play
function
role
promot
colon
cancer
metastasi
result
show
dcsignr
protein
dramat
induc
colon
cancer
cell
adhes
migrat
invas
properti
vitro
mous
dcsignr
human
dcsignr
involv
colon
cancer
liver
metastasi
vivo
furthermor
show
dcsignr
promot
liver
metastasi
colon
cancer
cell
novel
regulatori
pathway
dcsignr
notabl
increas
express
metallothionein
isoform
consist
observ
serum
level
dcsignr
significantli
higher
colon
cancer
patient
liver
metastasi
without
metastasi
sum
clearli
demonstr
dcsignr
critic
mediat
colon
cancer
liver
metastasi
found
serum
dcsignr
level
colon
cancer
patient
liver
metastasi
higher
without
metastasi
importantli
necessari
know
whether
colon
cancer
cell
express
dcsignr
detect
dcsignr
express
three
colon
cancer
cell
line
use
studi
either
flow
cytometri
western
blot
analysi
addit
file
figur
b
addit
laboratori
report
immunohistochem
stain
dcsignr
neg
match
colon
tissu
tumour
stroma
faintli
posit
colon
cancer
foci
thu
specul
dcsignr
express
liver
trigger
colon
cancer
cell
adhes
contribut
increas
liver
endotheli
cell
permeabl
enabl
transendotheli
migrat
invas
colon
cancer
cell
fig
express
dcsignr
increas
dcsignr
releas
bloodstream
colon
cancer
cell
appear
liver
may
explain
upregul
serum
level
solubl
dcsignr
colon
cancer
patient
liver
metastasi
dcsignr
transmembran
protein
commonli
consist
three
part
extracellular
transmembran
intracellular
domain
neck
domain
carbohydraterecognit
domain
crd
extracellular
domain
dcsignr
report
shown
mous
dcsignr
signific
homolog
human
dcsignr
crd
transmembran
domain
studi
ligand
bind
properti
indic
mous
dcsignr
interact
seri
fucosyl
oligosaccharid
lewisa
lexwisb
lewisx
lewisi
mannos
structur
adhes
receptor
addit
mous
dcsignr
also
bind
human
promot
lymphocyt
migrat
white
pulp
moreov
mous
dcsignr
also
abundantli
express
liver
lymph
node
similar
human
dcsignr
thu
mous
dcsignr
similar
human
dcsignr
demonstr
mous
dcsignr
involv
colon
cancer
liver
metastasi
downregul
express
mous
dcsignr
could
reduc
metastasi
tumour
howev
consid
structur
express
site
singl
orthologu
dcsignr
mice
strictli
ident
human
dcsignr
contrast
high
similar
crd
region
mous
dcsignr
much
shorter
neck
domain
compar
human
dcsignr
acid
neck
domain
encod
singl
exon
human
dcsignr
howev
mous
dcsignr
neck
domain
amino
acid
encod
four
small
exon
probabl
consequ
lesser
degre
homolog
mous
dcsignr
human
dcsignr
express
mous
dcsignr
similar
ident
human
dcsignr
mous
dcsignr
also
express
macrophag
spleen
margin
zone
lymph
node
medulla
periton
caviti
balbc
mice
seem
mous
dcsignr
attribut
human
dcsignr
dcsign
howev
mous
dcsignr
complet
replac
human
dcsignr
thu
also
observ
role
human
dcsignr
colon
cancer
liver
metastasi
consequ
found
human
dcsignr
also
particip
colon
cancer
liver
metastasi
increas
express
human
dcsignr
promot
occurr
colon
cancer
liver
metastasi
moreov
also
demonstr
dcsignr
regul
express
metallothionein
increas
express
metallothionein
prognost
indic
poor
surviv
mani
cancer
gastric
cancer
nonsmal
lung
cancer
breast
cancer
addit
metallothionein
also
report
correl
tumour
metastasi
squamou
cell
carcinoma
oesophagu
metallothionein
could
predict
lymph
node
statu
distant
metastasi
correl
cell
prolifer
potenti
overexpress
metallothionein
statist
common
primari
cutan
malign
melanoma
haematogen
metastas
independ
breslow
tumour
thick
colon
cancer
overexpress
metallothionein
prognost
indic
poor
overal
surviv
patient
colorect
cancer
independ
main
clinicopatholog
paramet
best
knowledg
studi
first
analys
express
profil
colon
cancer
cell
treat
dcsignr
protein
control
igg
use
microarray
interestingli
data
show
metallothionein
significantli
increas
h
dcsignr
protein
treatment
decreas
timedepend
manner
timecours
analys
metallothionein
express
also
report
research
exampl
nickel
significantli
increas
transcript
level
h
maxim
induct
occur
h
exposur
follow
subsequ
decreas
express
ren
et
al
demonstr
cadmiuminduc
metallothionein
mrna
express
timedepend
rat
show
mrna
express
level
substanti
increas
cd
treatment
peak
h
declin
addit
mrna
level
metallothionein
sertoli
cell
peak
h
wakida
et
al
found
mrna
express
significantli
increas
h
middl
cerebr
arteri
occlus
decreas
h
wildtyp
mous
brain
addit
sever
studi
report
function
metallothionein
regul
gene
famili
zincdepend
enzym
capabl
degrad
variou
extracellular
matrix
compon
associ
colon
cancer
liver
metastasi
ondrej
zitka
et
al
show
activ
higher
presenc
metallothionein
compar
experiment
mixtur
chipbas
gel
electrophoresi
similar
temperatur
effect
member
metallothionein
could
promot
breast
cancer
cell
invas
increas
express
level
activ
bind
site
promot
region
via
modul
anoth
member
could
modul
motil
invas
human
glioma
cell
line
upregul
well
interact
also
relat
associ
previou
studi
possibl
due
high
affin
metallothionein
heavi
metal
zinc
ion
shown
metallothionein
induc
activ
zincdepend
regulatori
protein
enzym
zincfing
transcript
factor
may
postul
zinc
ion
present
metallothionein
activ
degrad
variou
extracellular
matrix
protein
therefor
sinc
demonstr
express
metallothionein
increas
result
dcsignr
simul
also
wonder
whether
dcsignr
treatment
effect
express
surprisingli
found
express
increas
h
incub
dcsignr
protein
decreas
next
h
similar
metallothionein
degrad
collagen
high
effici
also
express
timedepend
manner
warren
find
indic
uterin
increas
respons
oestrogen
h
decreas
reach
basal
level
h
gilet
et
al
report
aldosteron
increas
mrna
level
cell
h
incub
express
peak
h
degrad
h
zhang
et
al
demonstr
lp
trigger
rapid
continu
increas
express
blood
sampl
h
incub
detect
h
studi
colon
cancer
cell
flow
blood
circul
arrest
site
liver
adher
sinusoid
cell
dcsignr
express
liver
endotheli
cell
increas
express
metallothionein
colon
cancer
cell
h
high
activ
actual
cellular
adhes
molecul
play
import
role
tumor
metastasi
adhes
interact
specif
adhes
molecul
receptor
intermedi
procedur
metastat
cascad
dcsignr
high
affin
captur
mannos
glycan
present
promot
infect
cell
tran
dcsignr
express
sinu
endotheli
cell
demonstr
form
continu
line
mediat
bind
lymphocyt
migrat
lymph
node
immun
respons
result
show
dcsignr
interact
colon
cancer
cell
dose
calciumdepend
manner
colon
cancer
cell
exhibit
significantli
specif
reduc
adhes
liver
tissu
extract
mice
inject
mous
dcsignr
shrna
plasmid
compar
tissu
taken
mice
inject
control
shrna
plasmid
number
colon
cancer
cell
adher
liver
tissu
augment
mice
inject
human
dcsignr
express
plasmid
interact
could
inhibit
dcsignr
antibodi
act
tandemrep
neck
domain
dcsignr
dcsignr
neck
region
essenti
lectin
tetramer
neck
structur
may
constitut
rigid
neck
support
crd
chang
angl
distanc
carbohydratebind
site
within
constitu
monom
thu
neck
domain
may
signific
impact
ligand
bind
thu
result
provid
first
experiment
evid
date
link
colon
cancer
cell
adhes
hepat
endotheli
dcsignr
progress
liver
metastasi
addit
cell
migrat
also
essenti
factor
tumour
metastasi
studi
found
dcsignr
increas
express
metallothionein
metallothionein
famili
cysteinerich
low
molecularweight
protein
addit
express
tumour
play
import
role
cell
migrat
therefor
influenc
metastat
abil
tumour
exampl
wu
et
al
report
one
metallothionein
consid
import
bladder
cancer
cell
migrat
tumour
stage
demonstr
induc
migrat
prolifer
invas
tripleneg
breast
cancer
cell
via
induct
metalloproteinas
express
anoth
key
molecular
mediat
dcsignr
colon
cancer
cell
product
secret
tumor
cell
vital
factor
involv
promot
metastasi
promot
tumour
progress
degrad
extracellular
matrix
facilit
cell
migrat
invas
metastasi
addit
silenc
express
decreas
cell
migrat
invas
induc
cell
aggreg
result
also
show
knockdown
lovo
cell
could
significantli
decreas
express
metallothionein
howev
distinct
effect
express
silenc
thu
conclud
dcsignr
import
regul
promot
colon
cancer
cell
migrat
invas
metastasi
activ
metallothionein
upregul
express
summari
studi
dcsignr
indic
novel
role
colon
cancer
liver
metastasi
dcsignr
may
promis
biomark
provid
new
therapeut
strategi
treatment
colon
cancer
